Skip to main content
. 2023 Oct 31;18:178. doi: 10.1186/s13014-023-02367-5

Table 2.

Adverse events (n = 20)

Grade 1 Grade 2 Grade 3 Grade 4
Nausea, n (%) 10 (50) 1 (5) 0 0
Fatigue, n (%) 4 (20) 1 (5) 0 0
Anorexia, n (%) 2 (10) 0 0 0
Vomiting, n (%) 2 (10) 0 0 0
Diarrhea, n (%) 1 (5) 0 0 0
Neutropenia, n (%) 0 0 2 (10)a 1 (5)a
Thrombocytopenia, n (%) 0 2 (10)b 0 1 (5)C

aGrade 3 or 4 neutropenia was judged as being related to the concurrent chemotherapy

bGrade 2 thrombocytopenia was attributed to disease progression

cGrade 4 thrombocytopenia was judged as having been caused by infection